Literature DB >> 29042829

Kinetics of N-Glycan Release from Human Immunoglobulin G (IgG) by PNGase F: All Glycans Are Not Created Equal.

Yining Huang1, Ron Orlando1.   

Abstract

The biologic activity of IgG molecules is modulated by its crystallizable fragment N-glycosylation, and thus, the analysis of IgG glycosylation is critical. A standard approach to analyze glycosylation of IgGs involves the release of the N-glycans by the enzyme peptide N-glycosidase F, which cleaves the linkage between the asparagine residue and innermost N-acetylglucosamine (GlcNAc) of all N-glycans except those containing a 3-linked fucose attached to the reducing terminal GlcNAc residue. The importance of obtaining complete glycan release for accurate quantitation led us to investigate the kinetics of this de-glycosylation reaction for IgG glycopeptides and to determine the effect of glycan structure and amino acid sequence on the rate of glycan release from glycopeptides of IgGs. This study revealed that the slight differences in amino acid sequences did not lead to a statistically different deglycosylation rate. However, statistically significant differences in the deglycosylation rate constants were observed between glycopeptides differing only in glycan structure (i.e., nonfucosylated, fucosylated, bisecting-GlcNAc, sialylated, etc.). For example, a single sialic acid residue was found to decrease the rate by a factor of 3. Similar reductions in rate were associated with the presence of a bisecting-GlcNAc. We predict the differences in release kinetics can lead to significant quantitative variations of the glycosylation study of IgGs.

Entities:  

Keywords:  Antibody; HILIC; LC-MS; de-glycsoylation

Mesh:

Substances:

Year:  2017        PMID: 29042829      PMCID: PMC5632957          DOI: 10.7171/jbt.17-2804-002

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  23 in total

1.  Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography.

Authors:  L E Matamoros Fernández; D E Kalume; L Calvo; M Fernández Mallo; A Vallin; P Roepstorff
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-03-10

2.  Structural analysis of an N-glycan with "beta1-4 bisecting branch" from human serum IgG by negative-ion MSn spectral matching and exoglycosidase digestion.

Authors:  Yasuhiro Takegawa; Kisaburo Deguchi; Hiroaki Nakagawa; Shin-Ichiro Nishimura
Journal:  Anal Chem       Date:  2005-09-15       Impact factor: 6.986

3.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

4.  Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.

Authors:  Jason Hodoniczky; Yuan Zhi Zheng; David C James
Journal:  Biotechnol Prog       Date:  2005 Nov-Dec

5.  Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.

Authors:  Y Mimura; P Sondermann; R Ghirlando; J Lund; S P Young; M Goodall; R Jefferis
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

6.  Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.

Authors:  Shigeru Iida; Hirofumi Misaka; Miho Inoue; Mami Shibata; Ryosuke Nakano; Naoko Yamane-Ohnuki; Masako Wakitani; Keiichi Yano; Kenya Shitara; Mitsuo Satoh
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

7.  Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.

Authors:  Lone A Omtvedt; Louise Royle; Gunnar Husby; Knut Sletten; Catherine M Radcliffe; David J Harvey; Raymond A Dwek; Pauline M Rudd
Journal:  Arthritis Rheum       Date:  2006-11

8.  On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies.

Authors:  Lynn A Gennaro; Oscar Salas-Solano
Journal:  Anal Chem       Date:  2008-04-22       Impact factor: 6.986

9.  Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG.

Authors:  David J Harvey; Max Crispin; Chris Scanlan; Bernhard B Singer; Lothar Lucka; Veronica T Chang; Catherine M Radcliffe; Smita Thobhani; Chun-Ting Yuen; Pauline M Rudd
Journal:  Rapid Commun Mass Spectrom       Date:  2008-04       Impact factor: 2.419

Review 10.  Impact of Glycosylation on Effector Functions of Therapeutic IgG.

Authors:  Riad Abès; Jean-Luc Teillaud
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-12
View more
  6 in total

1.  Mass Spectrometry-Based Methods for Immunoglobulin G N-Glycosylation Analysis.

Authors:  Siniša Habazin; Jerko Štambuk; Jelena Šimunović; Toma Keser; Genadij Razdorov; Mislav Novokmet
Journal:  Exp Suppl       Date:  2021

2.  Lectin and Liquid Chromatography-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

Authors:  Tea Petrović; Irena Trbojević-Akmačić
Journal:  Exp Suppl       Date:  2021

3.  Sample Preparation Scale-Up for Deep N-glycomic Analysis of Human Serum by Capillary Electrophoresis and CE-ESI-MS.

Authors:  Marton Szigeti; Andras Guttman
Journal:  Mol Cell Proteomics       Date:  2019-10-18       Impact factor: 5.911

4.  Changes in the Expression of Renal Brush Border Membrane N-Glycome in Model Rats with Chronic Kidney Diseases.

Authors:  Aiying Yu; Jingfu Zhao; Shiv Pratap S Yadav; Bruce A Molitoris; Mark C Wagner; Yehia Mechref
Journal:  Biomolecules       Date:  2021-11-11

5.  Altered O-glycomes of Renal Brush-Border Membrane in Model Rats with Chronic Kidney Diseases.

Authors:  Aiying Yu; Jingfu Zhao; Jieqiang Zhong; Junyao Wang; Shiv Pratap S Yadav; Bruce A Molitoris; Mark C Wagner; Yehia Mechref
Journal:  Biomolecules       Date:  2021-10-21

6.  Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity.

Authors:  Zhengping Hu; Issahy Cano; Kahira L Saez-Torres; Michelle E LeBlanc; Magali Saint-Geniez; Yin-Shan Ng; Pablo Argüeso; Patricia A D'Amore
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.